Matches in SemOpenAlex for { <https://semopenalex.org/work/W2488897835> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2488897835 abstract "Background: Upper Gastrointestinal Cancers (UGCs) respond poorly to conventional chemotherapy due to variable P53 status and overactive mechanisms that mediate drug resistance. Platinum based compounds like Cisplatin (CDDP) are frequently used for treatment of UGCs. However, clinical use of CDDP is limited due to development of drug resistance and dose limiting side-effects resulting in nausea, vomiting, neutropenia, thrombocytopenia and renal toxicity. In this study we investigated the anticancer potency of a novel CDDP derivative (dichloro [4,40-bis(4,4,4-trifluorobutyl)-2,20-bipyridine] platinum) (DCTF-CDDP) and compared it to CDDP in P53 wild type and mutant models of UGCs. Methods: For this study, we evaluated the effect of CDDP or its derivative (DCTF-CDDP) on AGS (P53 wild type) and FLO-1 (P53 mutant) UGC cell viability, survival, and expression of apoptotic markers. Results: The cell viability data indicated that DCTF-CDDP treatment was comparatively more effective than CDDP at inhibiting AGS (CDDP IC50: 6.3 ± 0.2 μM; DCTF IC50: 1.7 ± 0.5μM) and FLO-1 (CDDP IC50: 2.5 ± 0.68 μM; DCTF IC50: 0.5 ± 0.6μM) UGC cancer cell viability. The clonogenic cell survival assay data also showed that DCTF-CDDP was significantly (p Citation Format: Samhita Bapat, Tanmay Dichwalkar, Priya Pancholi, Byron L. Bennett, Vikas Sehdev. Dichloro [4,40-bis(4,4,4-trifluorobutyl)-2,20-bipyridine] platinum, a novel Cisplatin analog, exhibits enhanced anticancer activity in preclinical models of upper gastrointestinal cancers. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 4776." @default.
- W2488897835 created "2016-08-23" @default.
- W2488897835 creator A5007946816 @default.
- W2488897835 creator A5009165030 @default.
- W2488897835 creator A5017790868 @default.
- W2488897835 creator A5031370179 @default.
- W2488897835 creator A5039420734 @default.
- W2488897835 date "2016-07-15" @default.
- W2488897835 modified "2023-09-25" @default.
- W2488897835 title "Abstract 4776: Dichloro [4,40-bis(4,4,4-trifluorobutyl)-2,20-bipyridine] platinum, a novel Cisplatin analog, exhibits enhanced anticancer activity in preclinical models of upper gastrointestinal cancers" @default.
- W2488897835 doi "https://doi.org/10.1158/1538-7445.am2016-4776" @default.
- W2488897835 hasPublicationYear "2016" @default.
- W2488897835 type Work @default.
- W2488897835 sameAs 2488897835 @default.
- W2488897835 citedByCount "0" @default.
- W2488897835 crossrefType "proceedings-article" @default.
- W2488897835 hasAuthorship W2488897835A5007946816 @default.
- W2488897835 hasAuthorship W2488897835A5009165030 @default.
- W2488897835 hasAuthorship W2488897835A5017790868 @default.
- W2488897835 hasAuthorship W2488897835A5031370179 @default.
- W2488897835 hasAuthorship W2488897835A5039420734 @default.
- W2488897835 hasConcept C117262875 @default.
- W2488897835 hasConcept C121608353 @default.
- W2488897835 hasConcept C126322002 @default.
- W2488897835 hasConcept C185592680 @default.
- W2488897835 hasConcept C190283241 @default.
- W2488897835 hasConcept C202751555 @default.
- W2488897835 hasConcept C2776694085 @default.
- W2488897835 hasConcept C2777752497 @default.
- W2488897835 hasConcept C2778239845 @default.
- W2488897835 hasConcept C502942594 @default.
- W2488897835 hasConcept C53227056 @default.
- W2488897835 hasConcept C55493867 @default.
- W2488897835 hasConcept C71924100 @default.
- W2488897835 hasConcept C98274493 @default.
- W2488897835 hasConceptScore W2488897835C117262875 @default.
- W2488897835 hasConceptScore W2488897835C121608353 @default.
- W2488897835 hasConceptScore W2488897835C126322002 @default.
- W2488897835 hasConceptScore W2488897835C185592680 @default.
- W2488897835 hasConceptScore W2488897835C190283241 @default.
- W2488897835 hasConceptScore W2488897835C202751555 @default.
- W2488897835 hasConceptScore W2488897835C2776694085 @default.
- W2488897835 hasConceptScore W2488897835C2777752497 @default.
- W2488897835 hasConceptScore W2488897835C2778239845 @default.
- W2488897835 hasConceptScore W2488897835C502942594 @default.
- W2488897835 hasConceptScore W2488897835C53227056 @default.
- W2488897835 hasConceptScore W2488897835C55493867 @default.
- W2488897835 hasConceptScore W2488897835C71924100 @default.
- W2488897835 hasConceptScore W2488897835C98274493 @default.
- W2488897835 hasLocation W24888978351 @default.
- W2488897835 hasOpenAccess W2488897835 @default.
- W2488897835 hasPrimaryLocation W24888978351 @default.
- W2488897835 hasRelatedWork W1503226874 @default.
- W2488897835 hasRelatedWork W150585746 @default.
- W2488897835 hasRelatedWork W2018558719 @default.
- W2488897835 hasRelatedWork W2027555913 @default.
- W2488897835 hasRelatedWork W2032553799 @default.
- W2488897835 hasRelatedWork W2034940403 @default.
- W2488897835 hasRelatedWork W2061260524 @default.
- W2488897835 hasRelatedWork W2066146417 @default.
- W2488897835 hasRelatedWork W2076485964 @default.
- W2488897835 hasRelatedWork W2105013500 @default.
- W2488897835 hasRelatedWork W2141247241 @default.
- W2488897835 hasRelatedWork W2234785744 @default.
- W2488897835 hasRelatedWork W2327280696 @default.
- W2488897835 hasRelatedWork W2493885788 @default.
- W2488897835 hasRelatedWork W2810125342 @default.
- W2488897835 hasRelatedWork W2913940592 @default.
- W2488897835 hasRelatedWork W2956001841 @default.
- W2488897835 hasRelatedWork W3142865514 @default.
- W2488897835 hasRelatedWork W347991881 @default.
- W2488897835 hasRelatedWork W845054423 @default.
- W2488897835 isParatext "false" @default.
- W2488897835 isRetracted "false" @default.
- W2488897835 magId "2488897835" @default.
- W2488897835 workType "article" @default.